← FDA Drug Approvals (Drugs@FDA)
PACLITAXEL
NDA · New Drug Application · Sponsor: TEVA PHARMS INC · Approved 2023-05-11
Drug application
- FDA Application #
NDA216338- Application type
- New Drug Application
- Brand name
- PACLITAXEL
- Generic name
- PACLITAXEL
- Active ingredients
- PACLITAXEL
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS INC
- Manufacturer
- Teva Pharmaceuticals, Inc.
- First approval
- 2023-05-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown